These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35335017)

  • 1. Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients.
    Prasad N; Yadav B; Singh M; Gautam S; Bhadauria D; Patel M; Kushwaha R; Yadav D; Singh A; Yachha M; Behera M; Kaul A
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center.
    Prasad N; Bansal SB; Yadav B; Manhas N; Yadav D; Gautam S; Kushwaha R; Singh A; Bhadauria D; Yachha M; Behera MR; Kaul A
    Front Immunol; 2022; 13():911738. PubMed ID: 35844596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients.
    Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A
    Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines.
    Choudhary HR; Parai D; Chandra Dash G; Kshatri JS; Mishra N; Choudhary PK; Pattnaik D; Panigrahi K; Behera S; Ranjan Sahoo N; Podder S; Mishra A; Raghav SK; Mishra SK; Pradhan SK; Sahoo SK; Pattnaik M; Rout UK; Nanda RR; Mondal N; Kanungo S; Palo SK; Bhattacharya D; Pati S
    Front Med (Lausanne); 2021; 8():778129. PubMed ID: 35004746
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.
    Arankalle V; Kulkarni-Munje A; Kulkarni R; Palkar S; Patil R; Oswal J; Lalwani S; Mishra AC
    Front Immunol; 2022; 13():928501. PubMed ID: 36211366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Effectiveness of SARS-CoV-2 Vaccination in Renal Transplant Recipients. Antibody Levels Impact in Pneumonia and Death.
    Rodríguez-Cubillo B; Moreno de la Higuera MA; Pérez-Flores I; Calvo Romero N; Aiffil AS; Arribi Vilela A; Peix B; Huertas S; Juez A; Sanchez-Fructuoso AI
    Transplantation; 2022 Nov; 106(11):e476-e487. PubMed ID: 35859270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.
    Bansal D; Atia H; Al Badr M; Nour M; Abdulmajeed J; Hasan A; Al-Hajri N; Ahmed L; Ibrahim R; Zamel R; Mohamed A; Pattalaparambil H; Daraan F; Chaudhry A; Oraby S; El-Saleh S; El-Shafie SS; Al-Farsi AF; Paul J; Ismail A; Al-Romaihi HE; Al-Thani MH; Doi SAR; Zughaier SM; Cyprian F; Farag E; Farooqui HH
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD
    Dash GC; Subhadra S; Turuk J; Parai D; Rath S; Sabat J; Rout UK; Kanungo S; Choudhary HR; Nanda RR; Pattnaik M; Pati S; Bhattacharya D
    J Med Virol; 2022 Mar; 94(3):1201-1205. PubMed ID: 34622961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India.
    Singh B; Seema K; Mahuli AV; Kumar A; Boipai M; Sharma AK; Kumar M; Kumar S; Chandra S; Shahi AK
    Cureus; 2023 Oct; 15(10):e47566. PubMed ID: 38021860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study.
    Parai D; Choudhary HR; Dash GC; Behera S; Mishra N; Pattnaik D; Raghav SK; Mishra SK; Sahoo SK; Swain A; Mohapatra I; Pattnaik M; Moharana A; Jena SR; Praharaj I; Subhadra S; Kanungo S; Bhattacharya D; Pati S
    Front Microbiol; 2022; 13():942659. PubMed ID: 36016787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Human Leucocyte Antigen Polymorphism with Coronavirus Disease 19 in Renal Transplant Recipients.
    Prasad N; Yadav B; Prakash S; Yadav D; Singh A; Gautam S; Bhadauria D; Kaul A; Patel MR; Behera MR; Kushwaha RS; Yachha M
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression.
    Thomas RE; Sukumaran A; Krishnan R A; Thomas T; Edwin BT; Haritha PR; Varghese BM; Paul JK; Kumar C S S; Vasudevan DM
    Indian J Clin Biochem; 2023 Jan; 38(1):51-58. PubMed ID: 35465605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of anti-SARS-CoV-2 IgG antibody immune responses in two cohorts of Hungarian healthcare workers following infection or immunization].
    Gervain J; Szabóné Bartha K; Bakiné Hodovánszky E; Kadlecsik L; Herczeg R; Gyenesei A; Simon J
    Orv Hetil; 2022 Mar; 163(12):455-462. PubMed ID: 35306478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review.
    Das S; Kar SS; Samanta S; Banerjee J; Giri B; Dash SK
    Immunol Res; 2022 Jun; 70(3):289-315. PubMed ID: 35192185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19 Vaccines Available in India.
    Mukim M; Sharma P; Patweker M; Patweker F; Kukkar R; Patel R
    Comb Chem High Throughput Screen; 2022; 25(14):2391-2397. PubMed ID: 35293291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India.
    Satpathi PS; Endow S; Gantait K; Chand PH; Jaiswal A; Jana B; Kundu P; Ghosh T
    Iran J Microbiol; 2022 Oct; 14(5):611-616. PubMed ID: 36531814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.